Bezafibrate
Approved
Contents
Description
Bezafibrate is a fibric acid derivative used to treat hyperlipidemia. It is sometimes used off-label in the management of carnitine palmitoyltransferase II deficiency to improve energy metabolism.
Indications & Therapeutic Use
Hyperlipidemia, Carnitine palmitoyltransferase II deficiency (off-label)
Linked Diseases:
Global Availability (3 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Bezafibrate — GNH India
39 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Befizal
EU
Befizal L.P.
EU
Bezafibrat Abz
EU
Bezafibrat Al
EU
Bezafibrat Arena
EU
Bezafibrat Ratiopharm
EU
Bezafibrat Retard Al
EU
Bezafibrat Stada
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Bezafibrate
| Generic Name | Bezafibrate |
| Brands | 1 brand available |
| Active Ingredient | Bezafibrate |
| Drug Class | Hyperlipidemia |
| Dosage Forms | Oral tablet |
| Medical Code | C10AB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | Approved |
| Countries | 3 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations4 Validated Nodes